Mannatech (MTEX) Stock Price, News & Analysis

Company Overview

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Key Stats

• Today's Range: $8.12 to $8.33
• 50-Day Range: $7.58 to $9.99
• 52-Week Range: $7.05 to $16.49
• Volume: 6,051 shs
• Average Volume: 21,327 shs
• Market Capitalization: $16.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Mannatech Stock Analysis - MarketRank™

Mannatech scored higher than 6% of companies evaluated by MarketBeat, and ranked 912th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Mannatech.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Mannatech is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mannatech is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Mannatech has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.93% of the float of Mannatech has been sold short.

Short Interest Ratio / Days to Cover

Mannatech has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mannatech has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Mannatech does not currently pay a dividend.

Dividend Growth

Mannatech does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.93% of the float of Mannatech has been sold short.

Short Interest Ratio / Days to Cover

Mannatech has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mannatech has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for MTEX on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Mannatech insiders have not sold or bought any company stock.

Percentage Held by Insiders

41.50% of the stock of Mannatech is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 12.98% of the stock of Mannatech is held by institutions.

MTEX Stock Analysis - Frequently Asked Questions

How have MTEX shares performed this year?

Mannatech's stock was trading at $13.43 at the beginning of the year. Since then, MTEX stock has decreased by 36.6% and is now trading at $8.5150.

How were Mannatech's earnings last quarter?

Mannatech, Incorporated (NASDAQ:MTEX) announced its quarterly earnings results on Tuesday, August, 12th. The company reported ($2.27) earnings per share for the quarter. The business had revenue of $25.68 million for the quarter. Mannatech had a negative trailing twelve-month return on equity of 48.60% and a negative net margin of 3.46%.

Who are Mannatech's major shareholders?

Top institutional investors of Mannatech include Bridgeway Capital Management LLC (1.52%). Insiders that own company stock include Larry A Jobe, Kevin Andrew Robbins and Alfredo Bala.
View institutional ownership trends.

How do I buy shares of Mannatech?

Shares of MTEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Mannatech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mannatech investors own include CrowdStrike (CRWD), Walt Disney (DIS), Herbalife (HLF), Roku (ROKU), Alibaba Group (BABA), Enphase Energy (ENPH) and Enterprise Products Partners (EPD).

Company Calendar

• Last Earnings: 8/12/2025
• Today: 8/22/2025
• Next Earnings (Estimated): 11/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:MTEX
• CIK: 1056358
• Web: www.mannatech.com
• Phone: (972) 471-7400
• Fax: 972-471-8117
• Employees: 250
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.49 million
• Net Margins: -3.46%
• Pretax Margin: -3.06%
• Return on Equity: -48.60%
• Return on Assets: -10.70%

Debt

• Debt-to-Equity Ratio: 0.58
• Current Ratio: 1.11
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $117.87 million
• Price / Sales: 0.14
• Cash Flow: $2.14 per share
• Price / Cash Flow: 3.98
• Book Value: $3.14 per share
• Price / Book: 2.71

Miscellaneous

• Outstanding Shares: 1,900,000
• Free Float: 1,112,000
• Market Cap: $16.18 million
• Optionable: Not Optionable
• Beta: 0.84